Literature DB >> 12865947

Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.

Alex E Roher1, Yu-Min Kuo, Chera Esh, Carmen Knebel, Nicole Weiss, Walter Kalback, Dean C Luehrs, Jennifer L Childress, Thomas G Beach, Roy O Weller, Tyler A Kokjohn.   

Abstract

Alzheimer's disease (AD) is characterized by neurofibrillary tangles and by the accumulation of beta-amyloid (Abeta) peptides in senile plaques and in the walls of cortical and leptomeningeal arteries as cerebral amyloid angiopathy (CAA). There also is a significant increase of interstitial fluid (ISF) in cerebral white matter (WM), the pathological basis of which is largely unknown. We hypothesized that the accumulation of ISF in dilated periarterial spaces of the WM in AD correlates with the severity of CAA, with the total Abeta load in the cortex and with Apo E genotype. A total of 24 AD brains and 17 nondemented age-matched control brains were examined. CAA was seen in vessels isolated from brain by using EDTA-SDS lysis stained by Thioflavin-S. Total Abeta in gray matter and WM was quantified by immunoassay, ApoE genotyping by PCR, and dilatation of perivascular spaces in the WM was assessed by quantitative histology. The study showed that the frequency and severity of dilatation of perivascular spaces in the WM in AD were significantly greater than in controls (P< 0.001) and correlated with Abeta load in the cortex, with the severity of CAA, and with ApoE epsilon4 genotype. The results of this study suggest that dilation of perivascular spaces and failure of drainage of ISF from the WM in AD may be associated with the deposition of Abeta in the perivascular fluid drainage pathways of cortical and leptomeningeal arteries. This failure of fluid drainage has implications for therapeutic strategies to treat Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865947      PMCID: PMC1430731     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  27 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance.

Authors:  H F Cserr; C J Harling-Berg; P M Knopf
Journal:  Brain Pathol       Date:  1992-10       Impact factor: 6.508

3.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; T A Newman; M Hutchings; Y M Kuo; A E Roher
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Widespread dilatation of perivascular spaces: a leukoencephalopathy causing dementia.

Authors:  C Vital; J Julien
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

5.  Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes.

Authors:  H Pollock; M Hutchings; R O Weller; E T Zhang
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

Review 6.  Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; Y M Kuo; A E Roher
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

7.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 8.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

Review 9.  Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis.

Authors:  R O Weller
Journal:  J Neuropathol Exp Neurol       Date:  1998-10       Impact factor: 3.685

Review 10.  Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man.

Authors:  R O Weller; S Kida; E T Zhang
Journal:  Brain Pathol       Date:  1992-10       Impact factor: 6.508

View more
  100 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  The feasibility of quantitative MRI of perivascular spaces at 7T.

Authors:  Kejia Cai; Rongwen Tain; Sandhitsu Das; Frederick C Damen; Yi Sui; Tibor Valyi-Nagy; Mark A Elliott; Xiaohong J Zhou
Journal:  J Neurosci Methods       Date:  2015-09-08       Impact factor: 2.390

3.  Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging.

Authors:  W Chen; X Song; Y Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

Review 4.  Perivascular space and neurological disorders.

Authors:  Guan Wang
Journal:  Neurosci Bull       Date:  2009-02       Impact factor: 5.203

Review 5.  Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Authors:  Adam M Brickman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

Review 6.  Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.

Authors:  Tyler A Kokjohn; Alex E Roher
Journal:  Alzheimers Dement       Date:  2009-07       Impact factor: 21.566

7.  White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?

Authors:  Andreas Charidimou; Zane Jaunmuktane; Jean-Claude Baron; Matthew Burnell; Pascale Varlet; Andre Peeters; John Xuereb; Rolf Jäger; Sebastian Brandner; David J Werring
Journal:  Neurology       Date:  2013-11-27       Impact factor: 9.910

Review 8.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

9.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

10.  White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies.

Authors:  Poornima Venkat; Michael Chopp; Alex Zacharek; Chengcheng Cui; Li Zhang; Qingjiang Li; Mei Lu; Talan Zhang; Amy Liu; Jieli Chen
Journal:  Neurobiol Aging       Date:  2016-11-19       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.